Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited demonstrates strong business quality and growth, supported by consistent revenue and profit expansion. The company's financial strength and capital allocation practices are robust, though profitability metrics show some variability. Its current valuation is high compared to its intrinsic value, suggesting a premium market perception.

Estimated Intrinsic Value & DCF Fair Value are available with Premium plans.

Apollo Hospitals demonstrates strong operational performance and growth trajectories across revenue, profit, and cash flow. While the business quality and financial health are robust, the current market valuation appears to be at a significant premium to its estimated intrinsic value. This suggests a high level of market expectation for sustained strong growth and profitability.

• Robust revenue growth CAGR of 14.85%, indicating strong market penetration and demand.
• Exceptional PAT and EPS growth at 27.31% and 26.84% CAGR respectively, enhancing shareholder value.
• High business quality and financial strength scores (78 each), underpinning operational stability.
• Strong cash flow generation, evidenced by a 45.12% FCF CAGR and a 147.07% OCF to PAT conversion.